Cooper Companies, Inc.
- COO ยท Nasdaq
- Ophthalmic Goods
- San Ramon, CA
- 500 employees
- CIK 0000711404
Updated from SEC filings through
Top things to know
Revenue, FY2025$4.1B+5.1% vs FY2024Operating margin16.7%Operating income $683MEmployees500As of October 31, 2025Next earningsDecember 3, 2026AnnouncedLatest 8-KDeparture or appointment of directors or officers; compensationFiled October 27, 2026Leadership changeItem 5.02 filedOctober 27, 2026, last 90 days
Executives
- Al White President and CEO of CooperCompanies 8-K, 2026-09-09
- Albert G. White III President & CEO 4/A, 2026-02-13
-
Brian G. Andrews EVP, CFO & Treasurer 4/A, 2026-02-13 - Daniel G. McBride EVP & Chief Operating Officer 4, 2026-01-12
- Gerard H. Warner III President, CooperVision, Inc. 4, 2026-01-12
- Holly R. Sheffield President, CSI 4, 2026-01-12
What leadership is saying
“This quarter included a number of notable developments including earnings exceeding expectations, record free cash flow, solid fertility growth at CooperSurgical, and a favorable completion of a significant tax matter. At CooperVision, however, we proactively reduced U.S. channel inventory that weighed on our results and will continue to impact Q4”
Earnings press release (8-K Ex. 99.1), filed September 9, 2026
Cooper Companies, Inc. is a U.S. public company in ophthalmic goods (SIC 3851), headquartered in San Ramon, CA. It trades as COO on Nasdaq. Revenue was $4.1B in the fiscal year ending October 31, 2025, +5.1% from the year before. It reported about 500 employees. Al White is President and CEO of CooperCompanies.
Five-year financials
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $4.1B 10-K, 2025-12-05 | $3.9B 10-K, 2025-12-05 | $3.6B 10-K, 2025-12-05 | $3.3B 10-K, 2024-12-06 | $2.9B 10-K, 2023-12-08 |
| Operating income | $683M 10-K, 2025-12-05 | $706M 10-K, 2025-12-05 | $533M 10-K, 2025-12-05 | $508M 10-K, 2024-12-06 | $506M 10-K, 2023-12-08 |
| SG&A | $1.6B 10-K, 2025-12-05 | $1.5B 10-K, 2025-12-05 | $1.5B 10-K, 2025-12-05 | $1.3B 10-K, 2024-12-06 | $1.2B 10-K, 2023-12-08 |
| Net income | $375M 10-K, 2025-12-05 | $392M 10-K, 2025-12-05 | $294M 10-K, 2025-12-05 | $386M 10-K, 2024-12-06 | $2.9B 10-K, 2023-12-08 |
Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.
Leadership and board
| Name | Title | Source |
|---|---|---|
| Al White | President and CEO of CooperCompanies | 8-K, 2026-09-09 |
| Albert G. White III | President & CEO | 4/A, 2026-02-13 |
| Brian G. Andrews | EVP, CFO & Treasurer | 4/A, 2026-02-13 |
| Daniel G. McBride Executive Vice President, Chief Operating Officer at The Cooper Companies | EVP & Chief Operating Officer | 4, 2026-01-12 |
| Gerard H. Warner III | President, CooperVision, Inc. | 4, 2026-01-12 |
| Holly R. Sheffield | President, CSI | 4, 2026-01-12 |
| Teresa S. Madden | Director | 10-K, 2025-12-05 |
What Cooper Companies, Inc. does
The Cooper Companies, Inc. (Cooper, we or the Company), is a leading global medical device company focused on helping people experience life's beautiful moments. Headquartered in San Ramon, California, Cooper sells products in over 130 countries and positively impacts over fifty million lives each year.
Shares and governance
| Shares outstanding | 190.2 million (as of September 3, 2026) | 10-Q, September 9, 2026 |
|---|---|---|
| Public float | $16.2B (as of April 30, 2025) | 10-K, December 5, 2025 |
| Reportable segments | 2 (period ending July 31, 2026) | 10-Q, September 9, 2026 |
| Latest proxy statement | Meeting April 7, 2026 (filed February 24, 2026) | DEF 14A, February 24, 2026 |
| Auditor | Kpmg LLP (San Francisco, CA) | Latest 10-K |
Insider trades
Open-market buys and sales by officers and directors, from Forms 4 and 5. One row per filing.
| Date | Insider | Trade | Shares | Value | Source |
|---|---|---|---|---|---|
| September 16, 2026 | Lawrence Erik Kurzius Director | Buy | 10,000 | $549K | Form 4, September 17, 2026 |
| September 14, 2026 | Walter M. Rosebrough Jr Director | Buy | 10,000 | $542K | Form 4, September 15, 2026 |
| September 14, 2026 | Lawrence Erik Kurzius Director | Buy | 10,000 | $539K | Form 4, September 15, 2026 |
| September 11, 2026 | Paul A. Keel Director | Buy | 4,701 | $250K | Form 4, September 15, 2026 |
| December 22, 2025 | Cynthia L. Lucchese Director | Buy | 1,784 | $150K | Form 4, December 23, 2025 |
| December 18, 2025 | Maria Rivas Director | Buy | 1,000 | $82K | Form 4, December 19, 2025 |
| December 17, 2025 | Lawrence Erik Kurzius Director | Buy | 2,000 | $165K | Form 4, December 17, 2025 |
| December 16, 2025 | Holly R. Sheffield President, CSI | Buy | 1,230 | $99K | Form 4, December 16, 2025 |
Recent 8-K events
- 8-K filed 2026-10-27
- Item 5.02 Departure or appointment of directors or officers; compensation
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-09-09
- Item 2.02 Results of operations and financial condition (earnings release)
- Item 8.01 Other events
- 8-K filed 2026-06-04
- Item 2.02 Results of operations and financial condition (earnings release)
- Item 8.01 Other events
- 8-K filed 2026-05-04
- Item 5.02 Departure or appointment of directors or officers; compensation
- 8-K filed 2026-04-08
- Item 5.07 Submission of matters to a vote of security holders
- 8-K filed 2026-03-05
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-02-04
- Item 1.01 Entry into a material definitive agreement
- 8-K filed 2025-12-23
- Item 1.01 Entry into a material definitive agreement
- Item 5.02 Departure or appointment of directors or officers; compensation
- Item 7.01 Regulation FD disclosure
- 8-K filed 2025-12-12
- Item 5.02 Departure or appointment of directors or officers; compensation
- 8-K filed 2025-12-04
- Item 2.02 Results of operations and financial condition (earnings release)
- Item 5.02 Departure or appointment of directors or officers; compensation
- Item 7.01 Regulation FD disclosure
Frequently asked questions about Cooper Companies, Inc.
- What does Cooper Companies, Inc. do?
- In its own words, from Item 1 of its 10-K: "The Cooper Companies, Inc. (Cooper, we or the Company), is a leading global medical device company focused on helping people experience life's beautiful moments. Headquartered in San Ramon, California, Cooper sells products in over 130 countries and positively impacts over fifty million lives each year."
- What is Cooper Companies, Inc.'s revenue?
- $4.1B for the fiscal year ending October 31, 2025, from its 10-K filed December 5, 2025.
- Is Cooper Companies, Inc. profitable?
- Cooper Companies, Inc. reported net income of $375M for the fiscal year ending October 31, 2025.
- How many employees does Cooper Companies, Inc. have?
- About 500 as of October 31, 2025, as stated in its annual report.
- Who is the CEO of Cooper Companies, Inc.?
- Al White, President and CEO of CooperCompanies, as named in a 8-K filed September 9, 2026.
- Who is the CFO of Cooper Companies, Inc.?
- Brian G. Andrews, EVP, CFO & Treasurer, as named in a 4/A filed February 13, 2026.
- Where is Cooper Companies, Inc. headquartered?
- San Ramon, CA.
- What is Cooper Companies, Inc.'s stock ticker?
- COO on Nasdaq.
- What industry is Cooper Companies, Inc. in?
- Ophthalmic Goods, SIC code 3851.
- What is Cooper Companies, Inc.'s website?
- coopercos.com.
- When does Cooper Companies, Inc. report earnings next?
- December 3, 2026. Source: pg_future_events.
- Is Cooper Companies, Inc. a public company?
- Yes. Cooper Companies, Inc. files with the SEC under CIK 0000711404 and trades as COO.
- Who audits Cooper Companies, Inc.?
- Kpmg LLP, San Francisco, CA, as named in its latest annual report (10-K).
- How many shares of Cooper Companies, Inc. are outstanding?
- 190.2 million shares as of September 3, 2026, from its 10-Q filed September 9, 2026.
- What is Cooper Companies, Inc.'s public float?
- $16.2B as of April 30, 2025, as reported on the cover of its 10-K filed December 5, 2025.
- How many business segments does Cooper Companies, Inc. report?
- 2 reportable segments for the period ending July 31, 2026, from its 10-Q filed September 9, 2026.
- When is Cooper Companies, Inc.'s annual shareholder meeting?
- April 7, 2026, per its proxy statement (DEF 14A) filed February 24, 2026.
- Have Cooper Companies, Inc. insiders traded stock recently?
- Since September 2, 2025, officers and directors reported 0 open-market sales and 14 purchases worth about $4.4M on Forms 4 and 5. The most recent: Lawrence Erik Kurzius (Director) bought 10,000 shares on September 16, 2026.